UnitedHealth Stock Forecast: Trending Bullish Among Top Analysts

UnitedHealth (UNH) stock has fallen 0.0% over the past week, dropped 7.5% in the last month, and is down a steep 46.8% over the past year. Wall Street’s analysts are firmly bullish, with a StrongBuy consensus, forecasting a move toward a 12‑month average price target of $368.50 from the last close of $270.59.

Analyst John Ransom has just upgraded UNH to Buy with a new $330 price target, implying meaningful upside from current levels. He argues the selloff has created a compelling entry point as earnings could surprise to the upside over the next few years.

Ransom’s thesis rests on UnitedHealth’s announced and potential AI initiatives that aim to lower general and administrative costs relative to revenue. He also sees room for margin improvement at Optum Health, driven by better risk margins, lower expenses, and higher fee‑for‑service profitability.

The analyst highlights that UnitedHealth has shuttered or sold many smaller, unprofitable clinics and is refocusing on employed physicians and tighter networks, which could lift margins on roughly $58 billion of risk revenue. Even small improvements matter: every 100 basis points of G&A margin improvement or Medicare Advantage margin expansion could translate into meaningful gains in earnings per share.

Ransom now models modest annual G&A improvements in 2027–2028, lifting Optum Health EBIT from $2.2 billion in 2026 to $3.1 billion in 2028 and putting his 2027–2028 EPS forecasts about 7.5–8% above consensus. This N‑star analyst ranks 833 out of 12,068 on TipRanks, with a 57.55% success rate and 8.4% average return per rating. Never miss a stock rating. Find all the latest ratings on TipRanks’ Top Wall Street Analysts page.